Adeptus Health Inc. (Nasdaq: ADPT)
A class action has been filed in the United States District Court for the Eastern District of Texas, on behalf of purchasers of Adeptus Health Inc. (Nasdaq: ADPT) common stock between April 23, 2015 to November 16, 2015, (the “Class Period”).
The complaint charges Adeptus Health, certain of its officers and directors and the underwriters of its SPO with violations of the Securities Act and/or the Exchange Act. Adeptus Health owns and operates a network of independent freestanding emergency rooms in the United States.
The complaint alleges that defendants misrepresented and failed to disclose material adverse facts regarding the Company’s business and prospects, which were known to defendants or recklessly disregarded by them, including that: (a) Adeptus Health had been engaging in widespread predatory billing practices, particularly with respect to lower acuity level patients; (b) Adeptus Health’s predatory billing practices subjected the Company to numerous known, but undisclosed, risks, including monetary risks, reputational risks, risks associated with improper financial reporting, civil or criminal sanctions, and even exclusion from federal and state healthcare programs; (c) the Company’s financial statements had not been prepared in conformity with generally accepted accounting principles; (d) contrary to defendants’ representations about the Company’s practice of referring lower acuity patients to urgent care facilities, Adeptus Health routinely treated lower acuity patients and excessively billed them for the services it rendered; and (e) as a result of the foregoing, defendants lacked a reasonable basis for their positive statements about Adeptus Health’s then-current business and future financial prospects.
On November 17, 2015, KUSA, an NBC-affiliated television station located in Denver, Colorado, aired a 9WANTS To Know investigative report about the billing practices at Adeptus Health’s Colorado First Choice emergency rooms (“ERs”). According to the report, which had been based on “months” of investigation, the Company’s First Choice ERs engaged in a pattern and practice of predatory overbilling. In response to the airing of the KUSA investigative report, the price of Adeptus Health common stock plummeted more than 22% on very heavy trading volume, falling from $59.87 per share on November 16, 2015 to $46.50 per share on November 17, 2015.
If you are a current shareholder and purchased stock between April 23, 2015 to November 16, 2015, and would like to discuss your options of exercising your rights as a shareholder, please contact us.
Please submit the following information so we can determine if you qualify for the suit. If you don't know all the specific details, partial information is also acceptable.
Please Note: Neither the submission to nor the receipt of information by The Law Offices of Marc S. Henzel or one of its attorneys through this website constitutes an agreement by the firm to represent the individual and does not create an attorney-client relationship.